keyword
https://read.qxmd.com/read/38685366/bioaccessibility-of-bioactive-compounds-present-in-persea-americana-mill-seed-ingredient-during-oral-gastric-digestion-with-antibacterial-capacity-against-helicobacter-pylori
#1
JOURNAL ARTICLE
V Sánchez-Quezada, N Velázquez-Guadarrama, S Mendoza-Elizalde, M Hernandez-Iturriaga, P Vázquez Landaverde, G Loarca-Piña
ETHNOPHARMACOLOGICAL RELEVANCE: In ancient Mexican cultures, the Persea americana Mill seed has been used against gastrointestinal diseases, due to high concentrations of bioactive compounds. According to Traditional Mexican Medicine, P. americana seed aqueous infusion is used against roundworms, intestinal worms, parasites, and gastrointestinal problems, in a dose taken over three or four days. In addition, Mexican Society of Natural History indicates the traditional use of P. americana seed powder as an antiparasitic, and antibacterial (MTM, 2009)...
April 27, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38671427/appropriate-use-of-medication-among-home-care-adult-cancer-patients-at-end-of-life-a-retrospective-observational-study
#2
JOURNAL ARTICLE
Amani El Mughrabi, Sewar S Salmany, Batool Aljarrat, Ala'a Dabbous, Haya Ayyalawwad
BACKGROUND: Medications are commonly used for symptom control in cancer patients at the end of life. This study aimed to evaluate medication utilization among home care palliative patients with cancer at the end of life and assess the appropriateness of these medications. METHOD: This retrospective observational study included adult cancer patients who received home care in 2020. Medications taken during the last month of the patient's life were reviewed and classified into three major categories: potentially avoidable, defined as medications that usually have no place at the end of life because the time to benefit is shorter than life expectancy; medications of uncertain appropriateness, defined as medications that need case-by-case evaluation because they could have a role at the end of life; and potentially appropriate, defined as medications that provide symptomatic relief...
April 26, 2024: BMC Palliative Care
https://read.qxmd.com/read/38610738/proton-pump-inhibitors-and-cancer-risk-a-comprehensive-review-of-epidemiological-and-mechanistic-evidence
#3
REVIEW
Ibrahim O Sawaid, Abraham O Samson
Background: Proton pump inhibitors (PPIs) are commonly prescribed long-acting drugs used to treat acid reflux, gastroesophageal reflux disease (GERD), and peptic ulcers. Recently, concerns have been raised about their safety, particularly due to the association between long-term PPI use and cancer development. Multiple comprehensive studies have consistently suggested a noteworthy link between prolonged PPI usage and an increased risk of developing gastric, esophageal, colorectal, and pancreatic cancers, yet the precise underlying mechanism remains elusive...
March 28, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38607313/in-membrane-enrichment-and-peptic-digestion-to-facilitate-analysis-of-monoclonal-antibody-glycosylation
#4
JOURNAL ARTICLE
Junyan Yang, Raluca Ostafe, Merlin L Bruening
The number of therapeutic monoclonal antibodies (mAbs) is growing rapidly due to their widespread use for treating various diseases and health conditions. Assessing the glycosylation profile of mAbs during production is essential to ensuring their safety and efficacy. This research aims to rapidly isolate and digest mAbs for liquid chromatography-tandem mass spectrometry (LC-MS/MS) identification of glycans and monitoring of glycosylation patterns, potentially during manufacturing. Immobilization of an Fc region-specific ligand, oFc20, in a porous membrane enables the enrichment of mAbs from cell culture supernatant and efficient elution with an acidic solution...
April 12, 2024: Analytical Chemistry
https://read.qxmd.com/read/38604668/impact-of-large-scale-multicomponent-intervention-to-reduce-proton-pump-inhibitor-overuse-in-integrated-healthcare-system-difference-in-difference-study
#5
JOURNAL ARTICLE
Jacob E Kurlander, Loren Laine, Hyungjin Myra Kim, Christopher B Roberts, Darcy Saffar, Aimee Myers, Robert Holleman, Yuqing Gao, Michelle Shank, Richard Nelson, Jane Forman, Christian D Helfrich, Sarah L Krein, Sameer D Saini, Yu-Xiao Yang
OBJECTIVE: To determine how a large scale, multicomponent, pharmacy based intervention to reduce proton pump inhibitor (PPI) overuse affected prescribing patterns, healthcare utilization, and clinical outcomes. DESIGN: Difference-in-difference study. SETTING: US Veterans Affairs Healthcare System, in which one regional network implemented the overuse intervention and all 17 others served as controls. PARTICIPANTS: All individuals receiving primary care from 2009 to 2019...
April 11, 2024: BMJ: British Medical Journal
https://read.qxmd.com/read/38596495/vonoprazan-amoxicillin-dual-regimen-with-saccharomyces-boulardii-as-a-rescue-therapy-for-helicobacter-pylori-current-perspectives-and-implications
#6
EDITORIAL
Valerie Josephine Dirjayanto, Jessica Audrey, Daniel Martin Simadibrata
Yu et al 's study in the World Journal of Gastroenterology (2023) introduced a novel regimen of Vonoprazan-amoxicillin dual therapy combined with Saccharomyces boulardii ( S. boulardii ) for the rescue therapy against Helicobacter pylori ( H. pylori ) , a pathogen responsible for peptic ulcers and gastric cancer. Vonoprazan is a potassium-competitive acid blocker renowned for its rapid and long-lasting acid suppression, which is minimally affected by mealtime. Compared to proton pump inhibitors, which bind irreversibly to cysteine residues in the H+ /K+ -ATPase pump, Vonoprazan competes with the K+ ions, prevents the ions from binding to the pump and blocks acid secretion...
March 14, 2024: World Journal of Gastroenterology: WJG
https://read.qxmd.com/read/38582271/comparison-of-vonoprazan-versus-intravenous-proton-pump-inhibitor-for-prevention-of-high-risk-peptic-ulcers-rebleeding-after-successful-endoscopic-hemostasis-a-multicenter-randomized-noninferiority-trial
#7
JOURNAL ARTICLE
Tanawat Geeratragool, Uayporn Kaosombatwattana, Arpapun Boonchote, Suvikrom Chatthammanat, Nutchanun Preechakawin, Jompol Srichot, Asawin Sudcharoen, Pavapol Sirisunhirun, Panotpol Termsinsuk, Manus Rugivarodom, Julajak Limsrivilai, Monthira Maneerattanaporn, Nonthalee Pausawasdi, Somchai Leelakusolvong
BACKGROUND & AIMS: High-dose proton pump inhibitor (PPI) therapy has been recommended to prevent rebleeding of high-risk peptic ulcer (PU) after hemostasis. Vonoprazan has been proven to be noninferior to PPIs in various acid-related diseases. This study aims to compare the efficacy of vonoprazan versus PPI for preventing high-risk PU rebleeding after hemostasis. METHODS: A multicenter, randomized, noninferiority study was conducted in 6 centers. Pre-endoscopic and endoscopic therapy were performed according to standard protocol...
April 5, 2024: Gastroenterology
https://read.qxmd.com/read/38577188/treatment-of-helicobacter-pylori-with-potassium-competitive-acid-blockers-a-systematic-review-and-meta-analysis
#8
JOURNAL ARTICLE
Joseph Edwin Kanu, Jonathan Soldera
BACKGROUND: Helicobacter pylori ( H. pylori ) infects over half the global population, causing gastrointestinal diseases like dyspepsia, gastritis, duodenitis, peptic ulcers, G-MALT lymphoma, and gastric adenocarcinoma. Eradicating H. pylori is crucial for treating and preventing these conditions. While conventional proton pump inhibitor (PPI)-based triple therapy is effective, there's growing interest in longer acid suppression therapies. Potassium competitive acid blocker (P-CAB) triple and dual therapy are new regimens for H...
March 7, 2024: World Journal of Gastroenterology: WJG
https://read.qxmd.com/read/38570398/physiological-healing-of-chronic-gastric-ulcer-is-not-impaired-by-the-hydrogen-sulphide-h-2-s-releasing-derivative-of-acetylsalicylic-acid-atb-340-functional-and-proteomic-approaches
#9
JOURNAL ARTICLE
Edyta Korbut, Maciej Suski, Zbigniew Śliwowski, Dominik Bakalarz, Urszula Głowacka, Dagmara Wójcik-Grzybek, Grzegorz Ginter, Kinga Krukowska, Tomasz Brzozowski, Marcin Magierowski, John L Wallace, Katarzyna Magierowska
Gastric ulcers affect approx. 10% of population. Non-steroidal anti-inflammatory drugs (NSAIDs), including acetylsalicylic acid (ASA) predispose to or impair the physiologically complex healing of pre-existing ulcers. Since H2 S is an endogenous cytoprotective molecule, we hypothesized that new H2 S-releasing ASA-derivative (ATB-340) could overcome pathological impact of NSAIDs on GI regeneration.Clinically translational gastric ulcers were induced in Wistar rats using state-of-the-art microsurgical model employing serosal application of acetic acid...
April 3, 2024: Inflammopharmacology
https://read.qxmd.com/read/38566637/exploring-the-substantive-significance-of-laryngoscopic-observations-as-reliable-prognostic-indicators-for-the-therapeutic-efficacy-in-cases-of-laryngopharyngeal-reflux
#10
JOURNAL ARTICLE
Neeti Sahay, Ankita Soni, Samanvaya Soni, Amit Modwal, Man Prakash Sharma
Laryngopharyngeal reflux (LPR) can be defined as the regurgitation of gastric acid and peptic substances into the laryngeal and hypopharyngeal regions, even in the case of a singular occurrence. A substantial body of recent research underscores the significance of non-acid reflux as a notable contributor to LPR symptoms. This current investigation delves into the assessment of laryngoscopic observations in their predictive capacity regarding the therapeutic outcomes of empirically administered proton pump inhibitor (PPI) therapy in the context of LPR...
April 2024: Indian Journal of Otolaryngology and Head and Neck Surgery
https://read.qxmd.com/read/38530066/utility-of-mean-nocturnal-baseline-impedance-and-post-reflux-swallow-induced-peristaltic-wave-index-in-clinical-ph-impedance-reflux-study
#11
JOURNAL ARTICLE
Bianca Angelica, Marcus Tippett, Amanda Lim, Stephanie Wong, Paul Kuo
BACKGROUND AND AIMS: Analysis of mean nocturnal baseline impedance (MNBI) and post-reflux swallow-induced peristaltic wave index (PSPWi) have been proposed to increase the diagnostic yield of pH-impedance studies in reflux disease. However, routine use of these indices in clinical studies is yet to be established, particularly with PSPWi, which requires laborious manual analysis. Our study aimed to assess the utility of MNBI and PSPWi and their potential for future incorporation into clinical practice...
March 26, 2024: Internal Medicine Journal
https://read.qxmd.com/read/38517201/review-article-upper-gastrointestinal-bleeding-review-of-current-evidence-and-implications-for-management
#12
REVIEW
Dennis L Shung, Loren Laine
BACKGROUND: Acute upper gastrointestinal bleeding (UGIB) is a common emergency requiring hospital-based care. Advances in care across pre-endoscopic, endoscopic and post-endoscopic phases have led to improvements in clinical outcomes. AIMS: To provide a detailed, evidence-based update on major aspects of care across pre-endoscopic, endoscopic and post-endoscopic phases. METHODS: We performed a structured bibliographic database search for each topic...
May 2024: Alimentary Pharmacology & Therapeutics
https://read.qxmd.com/read/38492186/immunomodulatory-and-anti-inflammatory-effects-of-vitamin-a-and-tryptophan-on-monocyte-derived-dendritic-cells-stimulated-with-gliadin-in-celiac-disease-patients
#13
JOURNAL ARTICLE
Fatemeh Asgari, Abdolrahim Nikzamir, Kaveh Baghaei, Siamak Salami, Andrea Masotti, Mohammad Rostami-Nejad
Celiac Disease (CeD) is an autoimmune disorder with various symptoms upon gluten exposure. Dendritic cells (DCs) play a crucial role in gliadin-induced inflammation. Vitamin A (retinol; Ret) and its metabolite, retinoic acid (RA), along with tryptophan (Trp) and its metabolite, kynurenic acid (KYNA), are known to influence the immune function of DCs and enhance their tolerogenicity. This research aims to assess the impact of gliadin on DC maturation and the potential of vitamin A and tryptophan to induce immune tolerance in DCs...
March 16, 2024: Inflammation
https://read.qxmd.com/read/38483115/potassium-competitive-acid-blockers-and-acid-related-disorders
#14
JOURNAL ARTICLE
Kevin Z Huang, H Christian Weber
PURPOSE OF THE REVIEW: Potassium-competitive acid blockers (PCABs) represent a new class of compounds for the treatment of acid-related disorders. Recent FDA approval of the PCAB vonoprazan for erosive esophagitis has started an important new approach to acid-related disorders. RECENT FINDINGS: Compared to conventional proton pump inhibitors (PPIs), PCABs provide more rapid, potent, and sustained suppression of gastric acid with faster and more durable symptom relief...
March 15, 2024: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/38468980/unraveling-the-dynamics-of-esophageal-motility-esophagitis-severity-and-age-in-gerd-patients-a-cross-sectional-exploration
#15
JOURNAL ARTICLE
Ygor R Fernandes
BACKGROUND: Gastroesophageal reflux disease (GERD) is characterized by prolonged exposure of the esophageal mucosa to gastric content, with esophageal motility playing a pivotal role in its pathophysiology. This study employs a cross-sectional design to investigate the interplay between esophageal motility, the severity of esophagitis, and age in individuals presenting with GERD symptoms. OBJECTIVE: The primary objective is to assess proximal and distal esophageal contractions in individuals with GERD symptoms, exploring potential correlations with the severity of esophageal lesions and age...
February 2024: Curēus
https://read.qxmd.com/read/38467155/recent-advances-in-molecular-pathways-and-therapeutic-implications-for-peptic-ulcer-management-a-comprehensive-review
#16
JOURNAL ARTICLE
Deepak Chandra Joshi, Nirmal Joshi, Ajeet Kumar, Shubhrat Maheshwari
Peptic ulcers, recognized for their erosive impact on the gastrointestinal mucosa, present a considerable challenge in gastroenterology. Epidemiological insights underscore the global prevalence of peptic ulcers, affecting 5-10+% of individuals, with a yearly incidence of 0.3 to 1.9 cases per thousand. Recent decades have witnessed a decline in complications, attributed to improved diagnostics and therapeutic advancements. The review deepens into H. pylori -associated and NSAID-induced ulcers, emphasizing their distinct prevalence in developing and industrialized nations, respectively...
March 11, 2024: Hormone and Metabolic Research
https://read.qxmd.com/read/38464267/a-pilot-study-to-investigate-the-safety-and-feasibility-of-antiretroviral-therapy-for-alzheimer-s-disease-art-ad
#17
A Campbell Sullivan, Gabrielle Zuniga, Paulino Ramirez, Roman Fernandez, Chen-Pin Wang, Ji Li, Lisa Davila, Kristine Pelton, Sandra Gomez, Claira Sohn, Elias Gonzalez, Marisa Lopez-Cruzan, David A Gonzalez, Alicia Parker, Eduardo Zilli, Gabriel A de Erausquin, Sudha Seshadri, Sara Espinoza, Nicolas Musi, Bess Frost
Retrotransposons are viral-like DNA sequences that constitute approximately 41% of the human genome. Studies in Drosophila, mice, cultured cells, and human brain indicate that retrotransposons are activated in settings of tauopathy, including Alzheimer's disease, and causally drive neurodegeneration. The anti-retroviral medication 3TC (lamivudine), a nucleoside analog reverse transcriptase inhibitor, limits retrotransposon activation and suppresses neurodegeneration in tau transgenic Drosophila, two mouse models of tauopathy, and in brain assembloids derived from patients with sporadic Alzheimer's disease...
February 28, 2024: medRxiv
https://read.qxmd.com/read/38447558/h-pylori-infection-a-40-year-journey-through-shifting-the-paradigm-to-transforming-the-management
#18
REVIEW
Peter Malfertheiner, Christian Schulz, Richard H Hunt
Background Helicobacter pylori (H.pylori) was discovered 40 years ago and has set a milestone in human medicine. The discovery led to rejection of the dogma of the acidic stomach as a sterile organ and requested to rewrite the chapters on gastric pathophysiology and gastroduodenal diseases . Summary Over a period of 40 years following the discovery ,more than 50.000 articles can be retrieved in Pubmed as of today and illustrate the amount and the intensity of research around the role of this bacterium. H.pylori emerged as cause of chronic gastritis and principal cause of peptic ulcer disease (PUD)...
March 6, 2024: Digestive Diseases
https://read.qxmd.com/read/38447521/sporadic-zollinger-ellison-syndrome-in-a-patient-with-isolated-mesenteric-gastrinoma
#19
Boubacar Efared, Elh I M Tassiou, Aïchatou Balaraba Abani Bako, Idrissa Boubacar, Habiba Salifou Boureima, Hassan Nouhou
INTRODUCTION: Zollinger-Ellison syndrome (ZES) is due to a gastrin-producing neuroendocrine tumor (gastrinoma) with subsequent gastric acid hypersecretion, gastroesophageal reflux disease (GERD), peptic ulcers, and chronic diarrhea. CASE PRESENTATION: A 40-year old patient presented with epigastric pain associated with diarrhea evolving for 10 years, he has been treated by acid-suppressive medications without substantial clinical improvement. Gastro-duodenal endoscopy was performed with gastric biopsies that showed peptic ulcerations, a serum gastrin assay that showed high levels exceeding 10 times the upper limit of the normal range...
March 5, 2024: International Journal of Surgery Case Reports
https://read.qxmd.com/read/38436310/-clinical-characteristics-of-267-children-with-eosinophilic-gastrointestinal-disease-a-multicenter-study
#20
JOURNAL ARTICLE
Chun-Lei Zhan, Jie-Yu You, Xiao-Qin Li, Yong Wang, Xian-Qin Mei, Sheng-Hua Wan
OBJECTIVES: To explore the clinical manifestations, endoscopic findings, histopathological changes, treatment, and prognosis of eosinophilic gastrointestinal disease (EGID) in children, with the aim of enhancing awareness among pediatricians about this condition. METHODS: Data of 267 children with EGID were prospectively collected from January 2019 to July 2022 at Jiangxi Children's Hospital, Hunan Children's Hospital, and Henan Children's Hospital. The age of onset, symptoms, physical signs, laboratory examination results, endoscopic findings, histopathological changes, and treatment outcomes were observed...
February 15, 2024: Zhongguo Dang Dai Er Ke za Zhi, Chinese Journal of Contemporary Pediatrics
keyword
keyword
83837
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.